February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
November 3, 2022
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, is co-corresponding author of new research in JAMA Oncology that provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
November 7, 2022
MSN India highlighted recent research led by the University of Cincinnati's Trisha Wise-Draper about how immunotherapy and immunosuppression affects COVID-19 severity.
June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
April 14, 2023
The University of Cincinnati Cancer Center's Melinda Butsch Kovacic and colleagues will present research abstracts on several community outreach and engagement initiatives at the American Association for Cancer Research Annual Meeting 2023, held in Orlando, Florida, April 14-19.
October 23, 2023
The American Cancer Society has awarded the University of Cincinnati Cancer Center a $360,000 Institutional Research Grant that will provide pilot grant support for early-stage investigators working in cancer-related fields.
January 27, 2021
University of Cincinnati researchers have tested a new combination therapy that showed reduced growth of head and neck cancer in an animal-based study.
January 22, 2021
Researchers at the University of Cincinnati have tested a new combination therapy in head and neck cancer animal models to see if they could find a way to make an already effective treatment even better.
February 24, 2021
Climbing the ranks in the research field isn’t easy. Doing it with a physical disability is even more difficult. But Christina Wicker is doing just that at the University of Cincinnati.